FiercePharmaAsia—U.S.-China trade battle, Takeda-Shire deal insight, China’s generics push
admin 6th April 2018 Uncategorised 0A long list of biopharma products from China are proposed targets for additional U.S. tariffs, analysts now think the Takeda-Shire deal is “more likely than not,” China puts forward a policy package that favors generics over brands and more.
More: FiercePharmaAsia—U.S.-China trade battle, Takeda-Shire deal insight, China’s generics push
Source: fierce